Cathie Wood's ARK ETFs have made significant moves in the market for Monday, 22 July 2024, with a focus on technology and healthcare sectors. The largest transaction of the day was the sale of 804,849 shares of Teladoc Health Inc (NYSE:TDOC), signaling a sizable shift in ARK's portfolio composition. This move amounted to a substantial $7,316,077, marking the day's highest dollar-value trade.
In contrast, ARK showed a bolstered confidence in CrowdStrike Holdings Inc (NASDAQ:CRWD), purchasing a combined total of 20,219 shares across its ARKW and ARKF ETFs, valued at $6,165,986. This acquisition follows a pattern of consistent buying, as ARK had also increased its position in CrowdStrike on the previous Friday.
Tesla Inc (NASDAQ:TSLA), a usual heavyweight in ARK's trading activity, saw a reduction as 14,859 shares were sold from the ARKW ETF, equating to $3,554,272. This trade comes after a more significant sale of Tesla shares last Thursday, suggesting a possible trend of ARK divesting from the electric vehicle giant.
Another notable transaction included the sale of 65,171 shares of UiPath Inc (NYSE:NYSE:PATH) from the ARKG ETF, with a trade value of $785,310. This continues a series of sales in UiPath, which ARK has been offloading since last week.
On the buying side, ARK invested $2,406,052 in 10X Genomics Inc (NASDAQ:TXG), acquiring 144,075 shares across the ARKK and ARKG ETFs. This move aligns with ARK's ongoing interest in the genomics space, as evidenced by previous purchases of the company's stock.
Other smaller but still noteworthy trades included the purchase of 8,400 shares of Oklo Inc (OKLO) through the ARKQ ETF, valued at $72,323, and the sale of 11,026 shares of Kaspi.kz AO (LSE:KSPI) exclusively through the ARKF ETF.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.